S100A9 + Calprotectin (S100A8/A9 complex) Antibody [P14P6]

Catalog No.: F1711

Application: Reactivity: Human

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsils tissue with F1711 at 1:1000 dilution.

サイズ	価格(税別)	在庫状況
20uL	JPY 27800	国内在庫なし(納期7~10日)
100uL	JPY 64000	国内在庫あり
100uL*2	JPY 96000	お問い合わせ

代表番号: 045-509-1970\|電子メール：sales@selleck.co.jp よく尋ねられる質問

使用情報

Dilution
IHC1:1000

Application
IHC

Source
Mouse Monoclonal Antibody

Reactivity
Human

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

ポジティブコントロール	Human spleen, Human Hodgkins lymphoma
ネガティブコントロール

プロトコール

IHC
Experimental Protocol： Deparaffinization/Rehydration 1. Deparaffinize/hydrate sections: 2. Incubate sections in three washes of xylene for 5 min each. 3. Incubate sections in two washes of 100% ethanol for 10 min each. 4. Incubate sections in two washes of 95% ethanol for 10 min each. 5. Wash sections two times in dH2O for 5 min each. 6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min. Staining 1. Wash sections in dH2O three times for 5 min each. 2. Incubate sections in 3% hydrogen peroxide for 10 min. 3. Wash sections in dH2O two times for 5 min each. 4. Wash sections in wash buffer for 5 min. 5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature. 6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C. 7. Remove antibody solution and wash sections with wash buffer three times for 5 min each. 8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature. 9. Wash sections three times with wash buffer for 5 min each. 10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use. 11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity. 12. Immerse slides in dH2O. 13. If desired, counterstain sections with hematoxylin. 14. Wash sections in dH2O two times for 5 min each. 15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each. 16. Mount sections with coverslips and mounting medium.

IHC

Experimental Protocol：

Deparaffinization/Rehydration

1. Deparaffinize/hydrate sections:

2. Incubate sections in three washes of xylene for 5 min each.

3. Incubate sections in two washes of 100% ethanol for 10 min each.

4. Incubate sections in two washes of 95% ethanol for 10 min each.

5. Wash sections two times in dH2O for 5 min each.

6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.

Staining

1. Wash sections in dH2O three times for 5 min each.

2. Incubate sections in 3% hydrogen peroxide for 10 min.

3. Wash sections in dH2O two times for 5 min each.

4. Wash sections in wash buffer for 5 min.

5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.

6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.

7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.

8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.

9. Wash sections three times with wash buffer for 5 min each.

10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.

11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.

12. Immerse slides in dH2O.

13. If desired, counterstain sections with hematoxylin.

14. Wash sections in dH2O two times for 5 min each.

15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.

16. Mount sections with coverslips and mounting medium.

Datasheet & SDS

生物学的記述

Specificity
S100A9 + Calprotectin (S100A8/A9 complex) Antibody [P14P6] detects endogenous levels of total S100A9 + Calprotectin (S100A8/A9 complex) protein.

タンパク質の局在
細胞膜、細胞質、細胞骨格、細胞内膜系、細胞外環境

Uniprot ID
P06702

Clone
P14P6

Synonym(s)
CAGB, CFAG, MRP14, S100A9, Protein S100-A9, Calgranulin-B, Calprotectin L1H subunit, Leukocyte L1 complex heavy chain, Migration inhibitory factor-related protein 14, S100 calcium-binding protein A9, MRP-14, p14

Background
S100A9 + Calprotectin (S100A8/A9 complex) also known as myeloid-related proteins MRP8/MRP14, is a Ca²⁺-binding heterodimeric complex composed of S100A8 and S100A9, both members of the S100 protein family. Predominantly expressed in neutrophils, monocytes, and other immune cells, its expression is induced under inflammatory and stress conditions. Structurally, each subunit contains two EF-hand Ca²⁺-binding domains (low-affinity N-terminal and high-affinity C-terminal) connected by a hinge region, forming stable heterodimers or functional tetramers. Functionally, S100A8/A9 plays diverse roles in innate immunity and inflammation by regulating leukocyte chemotaxis, phagocyte migration, microtubule polymerization, reactive oxygen species production, and cytokine release. It also binds to receptors such as TLR4 and RAGE, activating downstream signaling pathways like MAPKs, PI3K/Akt, NF-κB, and mTOR. In cancer, S100A8/A9 modulates tumor growth, metastasis, apoptosis, drug resistance, and prognosis, making it a promising biomarker and therapeutic target.

Background

S100A9 + Calprotectin (S100A8/A9 complex) also known as myeloid-related proteins MRP8/MRP14, is a Ca²⁺-binding heterodimeric complex composed of S100A8 and S100A9, both members of the S100 protein family. Predominantly expressed in neutrophils, monocytes, and other immune cells, its expression is induced under inflammatory and stress conditions. Structurally, each subunit contains two EF-hand Ca²⁺-binding domains (low-affinity N-terminal and high-affinity C-terminal) connected by a hinge region, forming stable heterodimers or functional tetramers. Functionally, S100A8/A9 plays diverse roles in innate immunity and inflammation by regulating leukocyte chemotaxis, phagocyte migration, microtubule polymerization, reactive oxygen species production, and cytokine release. It also binds to receptors such as TLR4 and RAGE, activating downstream signaling pathways like MAPKs, PI3K/Akt, NF-κB, and mTOR. In cancer, S100A8/A9 modulates tumor growth, metastasis, apoptosis, drug resistance, and prognosis, making it a promising biomarker and therapeutic target.

References
[1] Zhou H, et al. Front Pharmacol. 2023 Aug 28;14:1187741.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%